Loading
Latest filing published 17 Jul 2026 for GSK plc, €2,164. Read the official filing
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Dr Harry Dietz on record concern GSK plc. The record holds 17 filings, for trades running from 20 June 2023 to 10 July 2026.
Purchases make up the whole of the open-market record (3 purchases, €29k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants.
In size, the median ticket on the buying side is €9,682. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 17 July 2026 came the latest disclosure, a share grant for €2,164 in GSK plc. The last purchase on record was published on 21 December 2023, which is 1,031 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. The legal deadline for notifying a trade is three business days (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations